LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Valerie W, McClain" <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 13 Oct 2004 06:50:43 EDT
Content-Type:
text/plain
Parts/Attachments:
text/plain (41 lines)
There is a patent application # 20040198694 called "Formulation to treat or
prevent parasitic infection," with the inventors being Michael Thomas
Clandinin.  This "invention" is to treat parasitic infections (gives example of
Giardia) and may be used in foods such as infant formula, baby food, baby cereal,
juice, etc.  Clandinin has done the original research on DHA and his work is
refered to in alot of DHA patents. Two of his papers that I recently looked at on
DHA were funded partly by Wyeth.  He is called Professor PUFA at the
University of Alberta, Canada.  He has a company called MTI which does "metabolic
assessments of new nutritionals and food (infant formulas and infant food, too).
It is stated that his research is the basis for world-wide acceptance of canola
oil and its GRAS status.

This patent application has an interesting statement that explains to me why
human milk research is about making a better infant formula.  The patent
states at one point, "In underprivileged areas of the world (third world
countries), infant formula supplementation, and supplementation for children may be used
to ward off infection and sustain health."

Thus, the desire to produce a safer infant formula is supposedly the root
cause of patenting human milk components and their gene constructs.  Yet this
creation--untested, of course he does have a company that makes assessments on
new food ingredients--will supposedly save infants in poverty from parasitic
infections.  The costliness of this enormous investment in making infant formula
safe not only impacts healthcare costs but has the rebound effect of
destroying breastfeeding in areas where it so badly needs to be promoted.  And if the
testing of these novel ingredients is done by those who have a financial
investment in those ingredients, then exactly how are we sure of its safety??
Valerie W. McClain, breastfeeding advocate

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2